Hepatitis B virus reactivation after ibrutinib treatment

被引：0
|
作者：
Alventosa Mateu, Carlos [1 ]
Urquijo Ponce, Juan Jose [1 ]
Mena Duran, Armando [2 ]
Latorre Sanchez, Mercedes [1 ]
Castello Miralles, Inmaculada [1 ]
Linares Garcia, Mariano [2 ]
Diago, Moises [1 ]
机构：
[1] Univ Valencia, Hepatol Unit, Valencia, Spain
[2] Univ Valencia, Consorcio Hosp Gen, Hematol Dept, Valencia, Spain
来源：
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS | 2024年 / 116卷 / 01期
关键词：
Hepatitis B virus; Reactivation; Ibrutinib; Prophylaxis;
D O I：
10.17235/reed.2023.9587/2023
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
New immunosuppressive and antineoplastic drugs are becoming both more numerous and more widely used, even during several years. Most of them present a low-moderate risk of hepatitis B virus (HBV) reactivation in HBsAg-negative and anti-HBc-positive patients. However, their reactivation capacity has not been clearly studied. We present the clinical case of a patient with these serological characteristics who, after 5 years of treatment with ibrutinib for chronic lymphocytic leukaemia, developed VHB reactivation, which was controlled with tenofovir. The occurrence of this event with drugs such as ibrutinib may lead to changes in HBV reactivation prophylaxis.
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [21] Case of hepatitis B virus reactivation after ibrutinib therapy in which the patient remained negative for hepatitis B surface antigens throughout the clinical course
    Tsuruya, Kota
    Anzai, Kazuya
    Shioyama, Shunsuke
    Ito, Ayano
    Arase, Yoshitaka
    Hirose, Shunji
    Tanaka, Yasuhito
    Suzuki, Hidekazu
    Kagawa, Tatehiro
    HEPATOLOGY RESEARCH, 2021, 51 (02) : 239 - 244
  • [22] Adefovir combined with hepatitis C virus treatment may prevent hepatitis B reactivation after hepatitis C virus eradication in hepatitis B and C virus carriers
    Renou, Christophe
    Cadranel, Jean-Francois
    Pariente, Alexandre
    Penaranda, Guillaume
    Bourliere, Marc
    Halfon, Philippe
    Igual, Jean-Pierre
    Harafa, Abdelouahid
    Muller, Pierre
    Bertrand, Jean-Jacques
    Laugier, Rene
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (12) : 1235 - 1237
  • [23] Hepatitis B virus reactivation after treatment for hepatitis C in hemodialysis patients with HBV/HCV coinfection
    Wahle, Raul Carlos
    Perez, Renata Mello
    Pereira, Patricia Fucuta
    Gomes Oliveira, Elze Maria
    Emori, Christini Takemi
    de Oliveira Uehara, Silvia Naomi
    de Souza Silva, Ivonete Sandra
    Benedito Silva, Antonio Eduardo
    Gomes Ferraz, Maria Lucia
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2015, 19 (05): : 533 - 537
  • [24] The effect of antiviral treatment on hepatitis B virus reactivation after radiotherapy for hepatocellular carcinoma
    Jun, B. G.
    Kim, Y. D.
    Cheon, G. J.
    Kim, S. G.
    Kim, Y. S.
    Jeong, S. W.
    Jang, J. Y.
    Lee, S. H.
    Kim, H. S.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S214 - S215
  • [25] Reactivation of hepatitis virus B infection in a patient with rheumatoid arthritis after treatment with rituximab
    Carlos Salman-Monte, Tarek
    Pilar Lisbona, Maria
    Garcia-Retortillo, Montserrat
    Maymo, Joan
    REUMATOLOGIA CLINICA, 2014, 10 (03): : 196 - 197
  • [26] Reactivation of Hepatitis B Virus After Glioblastoma Treatment With Temozolomide-Case Report
    Ohno, Makoto
    Narita, Yoshitaka
    Miyakita, Yasuji
    Ueno, Hideki
    Kayama, Takamasa
    Shibui, Soichiro
    NEUROLOGIA MEDICO-CHIRURGICA, 2011, 51 (10) : 728 - 731
  • [27] Successful Control of Hepatitis B Virus Reactivation following Restart of Ibrutinib in Chronic Lymphocytic Leukaemia
    Tjonnfjord, Sara Kristina Viberg
    Tjonnfjord, Eirik Brekka
    Konopski, Zbigniew
    Tjonnfjord, Geir Erland
    CASE REPORTS IN HEMATOLOGY, 2021, 2021
  • [28] Reactivation of hepatitis B after treatment with CHOP and rituximab
    Fernandez Fernandez, F. J.
    de la Fuente Aguado, J.
    Puerta Louro, R.
    Fernandez Villaverde, A.
    Soto Rios, C.
    REVISTA CLINICA ESPANOLA, 2007, 207 (04): : 220 - 220
  • [29] Late Hepatitis B reactivation after treatment with rituximab
    Pereira, Sara Lacerda
    Duro, Raquel
    Sarmento, Antonio
    IDCASES, 2022, 27
  • [30] Feasibility and safety of therapy with ibrutinib after antiviral control of hepatitis B virus (HBV) reactivation in chronic lymphocytic leukemia patients
    Molica, Stefano
    Levato, Luciano
    Mirabelli, Rosanna
    Tedeschi, Alessanda
    Lentini, Mirella
    LEUKEMIA & LYMPHOMA, 2018, 59 (11) : 2734 - 2736
12345